Lumenis has announced a new partnership with Laseraid, a leading supplier of aesthetic devices, to provide a new subscription model which allows clinics to increase their bottom line whilst improving patient outcome.

Under this new agreement, more clinics will be able to gain access to Lumenis’ unique Splendor X technology, with its proprietary inbuilt plume evacuator and HEPA filter, providing a safer environment for both operators and patients.

Founded in 2007 as an alternative to the existing upfront capital outlay model, Laseraid’s unique subscription model has quickly become a vital asset for clinics across Australia and New Zealand, looking for an affordable way to grow and expand their clinical offering quickly. The innovative company has offices in Sydney, Brisbane, Melbourne and London UK, offering the full suite of support services and now works with hundreds of clinics and practices across all of these markets.

“We are extremely excited to be partnering with one of the world’s leading aesthetic manufacturers, Lumenis,” said Laseraid CEO Farzad Hendi. “This partnership will further support our ongoing efforts to provide all Australian clinics access to the best-in-class devices in laser hair removal, and we are looking forward to clinics across Australia reaping the benefits of offering their patients SPLENDOR X treatments.”

SPLENDOR X is the world’s most advanced laser hair removal device, utilising both 1064nm Nd: YAG and 755nm Alexandrite laser systems powered by BLEND XTM technology for unprecedented power, speed, versatility, and coverage rate.

Capable of targeting all skin types, SPLENDOR X’s unique technology gives clinicians the ability to tailor each laser pulse to fit the patient’s specific skin type, hair colour and thickness. SPLENDOR X’s square-shaped laser targets hair removal and skin conditions with greater uniformity and accuracy than traditional round laser spots and decreases the number of sessions required.
The revolutionary device can also execute treatments beyond hair removal, including wrinkle reduction and vascular and pigmented lesions. Because it is
extremely efficient, SPLENDOR X reduces treatment times, making it an excellent investment for clinics. It is also the only laser hair removal device in the market with an inbuilt plume evacuator and HEPA filter, making it safer for clinicians and patients.

Lumenis ANZ’s Country Manager, Richard New said the partnership with Laseraid marks the start of an exciting new chapter for Lumenis: “SPLENDOR X is one of our most popular devices, and we have long been looking for a partner to assist us in giving clinics the opportunity to experience its superior capabilities, without the financial stress. This agreement with Laseraid does just that, and we are looking forward to a long and successful relationship with them ahead.”


About Lumenis

Lumenis is a global leader in the field of minimally invasive clinical solutions for the surgical, ophthalmology and aesthetic markets, and is a world-renowned expert in developing and distributing energy-based technologies, including laser, intense pulsed light (IPL) and radio frequency (RF). For more than 50 years, Lumenis’ ground-breaking products have redefined medical treatments and have set numerous technological and clinical gold standards.

For more information visit lumenis.com.au

Previous articleAesthetic Medicine News Roundup, 10 September 2021
Next articleThe goal achievement breakthrough